Fig. 2From: Quality of life and work functionality in severe asthma patients: the impact of biological therapiesMean clinical and functional outcomes before and after 6 months of biologic therapy. Mean clinical and functional outcomes before and after treatment (data reported as mean and 95% confidence interval). A Variation in FEV1%. B Variation in FeNO. C Variations in ACT; D Variation in BEC. Abbreviations: FEV1%, forced expiratory volume in the first second, percentage of predicted values; ACT, asthma control test; BEC, blood eosinophil count; FeNO: fractional exhaled nitric oxideBack to article page